Study to Evaluate the Effects of Oral Contraceptive on Hemostatic Parameters in Healthy Women
Study Title
- A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women
Teva Identifier
- PSE-HSP-203 | 2010-023215-34
ClinicalTrials.gov Identifier
- NCT01252186
Study Status
- Completed
Trial Condition(s)
- Hemostasis | Oral Contraceptive
Interventions
- Drug: 91-day Levonorgestrel Oral Contraceptive | Drug: 28-day Levonorgestrel Oral Contraceptive | Drug: 28-day Desogestrel Oral Contraceptive
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female
Age Range
- 18 Years to 40 Years
Trial Duration
- 11/01/2010 - 12/01/2011
Phase
- Phase 2
Study Type
Interventional
